BIO Ventures For Global Health, Pharma Companies Launch Africa Access Initiative To Improve Cancer Care, Research On Continent

Devex: Q&A: How the African Access Initiative plans to mitigate Africa’s cancer burden
“…BIO Ventures for Global Health joined with pharmaceutical companies [last] week to launch the African Access Initiative — a cancer-focused program that brings together oncology companies with African governments and hospitals to enhance health care capacity, foster cancer research, and increase the availability of life-saving cancer medicines. … [BVGH President Jennifer] Dent spoke with Devex about this group’s plans to couple the latest oncology technologies with business models that produce reasonable treatment options to reduce the number of cancer deaths in Africa…” (Roby, 6/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.